ELI LILLY & CO (LLY)
Clinical trial NCT06921759 updates: 1. primary completion date: 2026-05-01 → 2026-05-13 2. enrollment: 206 → 221 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06921759 updates: 1. primary completion date: 2026-05-01 → 2026-05-13 2. enrollment: 206 → 221 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical